Our Current Collaborations in Action
Partnership Opportunities
Explore our business collaboration models
In-Licensing
We focus on highly differentiated and innovative products to complement our portfolio, we are open to different business models including licensing of FDF and/or Bulk with supply, in addition to Tech transfer Our areas of focus are: Biosimilars, mRNA technology, small molecules with focus on oncology and hormones, and Vaccines with focus on epidemic diseases, Flu and COVID-19.
10+
9 Oncology small molecules
1 Biosimilar
5+
Partners
7+
Launched Products
Out-Licensing
Our Europe Product Portfolio contains 35+ products in EU CTD format, covering a wide range of differentiated dosage forms, including DPIs, transdermal patches, solid oral dosage forms, injectables, and ophthalmic preparations. Our portfolio spans multiple therapeutic areas, including Antiemetics, Anti-infectives, Cardiovascular, Diabetes, Neurology, Ophthalmology, Pain Management, Respiratory, Rheumatology, Urology, and Andrology.
60+
Marketing Authorizations
55+
Countries
40+
Partners in EU & UK
Contract Manufacturing
We are your Contract Manufacturing partner, driven by one clear purpose: expanding patient access to high-quality medicines. With a reliable, agile, and cost-effective platform, we bridge unmet medical needs while ensuring every product is delivered with excellence, compliance, and care.
70+
Ongoing Projects
30+
Products
10+
Partners in EU, UK and USA
Our Strategic Alliances
EVA Pharma and Lilly's partnership has led to significant milestones to begin distribution of the African-made insulin products and to reach one million people per year by 2030. This collaboration is part of the Lilly 30x30 initiative, which aims to improve access to quality healthcare for 30 million people living in limited -resource settings, annually, by 2030. Another achieved milestone in this collaboration is the launch of Verzenio in Egypt as part of the "100 Million Health" initiative, aiming to treat over 20,000 breast cancer patients annually. These achievements underscore the effectiveness of their collaboration in expanding healthcare access and delivering essential treatments across key regions.
Thanks for your interest in EVA Pharma
Fill up the form and our team will get back to you shortly
Follow Us
